The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often prescribed for hot flashes in menopausal women, according to an FDA statement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback